What's breaking now, across thousands of outlets.
(RTTNews) - Wednesday, Tiziana Life Sciences (TLSA) said it submitted a request to the FDA for Orphan Drug Designation for intranasal foralumab for the treatment of Multiple System Atrophy (MSA).
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
Key PointsT. Rowe Price pays out a nearly 5% dividend yield.
WARMINSTER, Pa., Sept. 30, 2026 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company focused on infectious disease…
VANCOUVER, British Columbia, Sept. 30, 2026 (GLOBE NEWSWIRE) — Terra Rossa Gold Ltd., (TSXV:TRR, OTCQB:TRGXF) (‘the Company’ or ‘Terra Rossa’), is pleased to provide an update to previously announced…
The Euro (EUR) is dropping sharply against the British Pound (GBP) on Wednesday, as UK data has endorsed recent claims by Bank of England (BoE) officials to hike interest rates, while German data…
Facing potential liability for harms related to climate change, major oil companies have again turned to the US Supreme Court, teeing up a case that could determine the fate of dozens of…
What does your next financial milestone look like?Perhaps it is growing savings, expanding a business, building a more diversified investment portfolio, or simply becoming more intentional about the…
